These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20659959)

  • 1. Dopamine agonist withdrawal syndrome and non-motor symptoms after Parkinson's disease surgery.
    Nirenberg MJ
    Brain; 2010 Nov; 133(11):e155; author reply e156. PubMed ID: 20659959
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
    Lang AE; Kleiner-Fisman G; Saint-Cyr JA; Miyasaki J; Lozano A
    Neurology; 2003 Jan; 60(1):154-5; author reply 154-5. PubMed ID: 12525751
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine dysregulation syndrome after deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    De la Casa-Fages B; Grandas F
    J Neurol Sci; 2012 Jan; 312(1-2):191-3. PubMed ID: 21872889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease.
    Bandini F; Primavera A; Pizzorno M; Cocito L
    Parkinsonism Relat Disord; 2007 Aug; 13(6):369-71. PubMed ID: 17049455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.
    Mercado R; Constantoyannis C; Mandat T; Kumar A; Schulzer M; Stoessl AJ; Honey CR
    Mov Disord; 2006 Sep; 21(9):1457-61. PubMed ID: 16721750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
    Houeto JL; Mesnage V; Welter ML; Mallet L; Agid Y; Bejjani BP
    Neurology; 2003 Jan; 60(1):154-5; author reply 154-5. PubMed ID: 12530402
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine agonist withdrawal syndrome in Parkinson disease.
    Rabinak CA; Nirenberg MJ
    Arch Neurol; 2010 Jan; 67(1):58-63. PubMed ID: 20065130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic nucleus stimulation in Parkinson's disease: the other side of the medallion.
    Temel Y
    Exp Neurol; 2008 Jun; 211(2):321-3. PubMed ID: 18410927
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of possible risk factors for the development of dopamine agonist withdrawal syndrome in Parkinson's disease.
    Cunnington AL; White L; Hood K
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1051-2. PubMed ID: 22677468
    [No Abstract]   [Full Text] [Related]  

  • 12. Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?
    Gronchi-Perrin A; Viollier S; Ghika J; Combremont P; Villemure JG; Bogousslavsky J; Burkhard PR; Vingerhoets F
    Mov Disord; 2006 Sep; 21(9):1465-8. PubMed ID: 16763974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of cognitive deficits following deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Fraraccio M; Ptito A; Sadikot A; Panisset M; Dagher A
    Arch Clin Neuropsychol; 2008 Jul; 23(4):399-408. PubMed ID: 18394859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease.
    Zaidel A; Spivak A; Grieb B; Bergman H; Israel Z
    Brain; 2010 Jul; 133(Pt 7):2007-21. PubMed ID: 20534648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep brain stimulation and continuous dopaminergic stimulation in advanced Parkinson's disease.
    Wolters ECh
    Parkinsonism Relat Disord; 2007 Sep; 13 Suppl():S18-23. PubMed ID: 17702631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in the medical treatment of Parkinson's disease].
    Chaná P
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S22-5. PubMed ID: 20082996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OFF-off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson's disease.
    Brodsky MA; Hogarth P; Nutt JG
    Mov Disord; 2006 Sep; 21(9):1487-90. PubMed ID: 16721730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
    Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
    Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradoxical role of dopamine after subthalamic nucleus deep brain stimulation--downstream is upstream in a circuit diagram. Comment on "Does dopamine still have a leading role in advanced Parkinson's disease after subthalamic stimulation?" (Stereotact Funct Neurosurg 2008;86: 184-186).
    Gross RE
    Stereotact Funct Neurosurg; 2008; 86(3):189-90. PubMed ID: 18477863
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis of antiparkinsonian drug reduction after bilateral subthalamic deep brain stimulation].
    Fehér G; Balás I; Komoly S; Dóczi T; Janszky J; Aschermann Z; Balázs E; Nagy F; Kovács N
    Ideggyogy Sz; 2010 Sep; 63(9-10):314-9. PubMed ID: 21033420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.